168 related articles for article (PubMed ID: 27416024)
1. Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.
Sarcina C; Tinelli C; Ferrario F; Visciano B; Pani A; De Silvestri A; De Simone I; Del Vecchio L; Terraneo V; Furiani S; Santagostino G; Corghi E; Pozzi C
PLoS One; 2016; 11(7):e0158584. PubMed ID: 27416024
[TBL] [Abstract][Full Text] [Related]
2. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
Sarcina C; Tinelli C; Ferrario F; Pani A; De Silvestri A; Scaini P; Del Vecchio L; Alberghini E; Buzzi L; Baragetti I; Pozzi C
Clin J Am Soc Nephrol; 2016 Jun; 11(6):973-981. PubMed ID: 27129712
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
4. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.
Pozzi C; Andrulli S; Pani A; Scaini P; Del Vecchio L; Fogazzi G; Vogt B; De Cristofaro V; Allegri L; Cirami L; Procaccini AD; Locatelli F
J Am Soc Nephrol; 2010 Oct; 21(10):1783-90. PubMed ID: 20634300
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria.
Zhong Z; Tang Y; Tan J; Tan L; Pei G; Qin W
Int Urol Nephrol; 2021 Jan; 53(1):121-127. PubMed ID: 32944888
[TBL] [Abstract][Full Text] [Related]
6. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[TBL] [Abstract][Full Text] [Related]
7. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
Min L; Wang Q; Cao L; Zhou W; Yuan J; Zhang M; Che X; Mou S; Fang W; Gu L; Zhu M; Wang L; Yu Z; Qian J; Ni Z
Oncotarget; 2017 Jul; 8(29):48375-48384. PubMed ID: 28415636
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial.
Pozzi C; Andrulli S; Del Vecchio L; Melis P; Fogazzi GB; Altieri P; Ponticelli C; Locatelli F
J Am Soc Nephrol; 2004 Jan; 15(1):157-63. PubMed ID: 14694168
[TBL] [Abstract][Full Text] [Related]
9. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
10. Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
Goumenos DS; Davlouros P; El Nahas AM; Ahuja M; Shortland JR; Vlachojannis JG; Brown CB
Nephron Clin Pract; 2003; 93(2):C58-68. PubMed ID: 12616032
[TBL] [Abstract][Full Text] [Related]
11. Combined Immunosuppressive Treatment May Improve Short-Term Renal Outcomes in Chinese Patients with Advanced IgA Nephropathy.
Tan L; Tang Y; Peng W; Mathew BS; Qin W
Kidney Blood Press Res; 2018; 43(4):1333-1343. PubMed ID: 30099439
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroid therapy in IgA nephropathy with minimal proteinuria and high renal pathological score: A single‑center cohort study.
Tang Y; He H; Sun W; Hu P; Chen X; Xu X
Mol Med Rep; 2018 Oct; 18(4):4103-4112. PubMed ID: 30132546
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria.
Nagasawa Y; Yamamoto R; Shinzawa M; Shoji T; Hasuike Y; Nagatoya K; Yamauchi A; Hayashi T; Kuragano T; Moriyama T; Isaka Y
Clin Exp Nephrol; 2020 Oct; 24(10):927-934. PubMed ID: 32642919
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
Tesar V; Troyanov S; Bellur S; Verhave JC; Cook HT; Feehally J; Roberts IS; Cattran D; Coppo R;
J Am Soc Nephrol; 2015 Sep; 26(9):2248-58. PubMed ID: 25677392
[TBL] [Abstract][Full Text] [Related]
16. Treatment of IgA nephropathy.
Pozzi C
J Nephrol; 2016 Feb; 29(1):21-5. PubMed ID: 26577268
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
18. IgA nephropathy with minimal change disease.
Herlitz LC; Bomback AS; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Clin J Am Soc Nephrol; 2014 Jun; 9(6):1033-9. PubMed ID: 24721885
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy.
Hirano K; Kawamura T; Tsuboi N; Okonogi H; Miyazaki Y; Ikeda M; Matsushima M; Hanaoka K; Ogura M; Utsunomiya Y; Hosoya T
Clin Exp Nephrol; 2013 Aug; 17(4):555-62. PubMed ID: 23224025
[TBL] [Abstract][Full Text] [Related]
20. Baseline proteinuria, urinary osmotic pressure, and renal function as positive predictors of corticosteroids plus cyclophosphamide treatment efficacy in IgA nephropathy.
Fang J; Li W; Li D; Tan Z
Chin Med J (Engl); 2014; 127(9):1710-4. PubMed ID: 24791879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
